Drug recall · August 22, 2018
Atorvastatin Calcium tablets recall
Why: Failed Impurities/Degradation Specifications - OOS was observed for ATV Cyclo FP Impurity and Total Degradation Impurities tested at the 18 month stability time point in Atorvastatin Calcium Tablets 40 mg 500 tablets.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Atorvastatin Calcium tablets, 40 mg, 500-count bottle, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 India, NDC 55111-123-05
- Lots / codes
T60045
- Quantity
- 2280 bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- U.S.A. Nationwide
- Initiated
- August 2, 2018 · Voluntary: Firm initiated
- Classified
- August 14, 2018
- Reported
- August 22, 2018
- Ended
- April 15, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atorvastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.